InsiderClue
Insiders · Profile

HAMED KAMAL

Chief Medical Officer at Spero Therapeutics. Filing since 13 Sep 2023. CIK 0001946366

Company
Date
Role
Action
Shares
Amount
Of holding
SPRO Spero Therapeutics, Inc.
2 Feb 2024
Chief Medical Officer
Sold at will
28,075
$38.46K
3.4%
SPRO Spero Therapeutics, Inc.
13 Sep 2023
Chief Medical Officer
Sold at will
39,496
$50.16K
6.4%
2 decisions on file.